JDRF Blog

Latest in Immunotherapies

  • JDRF-Backed Start-Up Company to Accelerate Work Through Pfizer

    March 5, 2019

    AnTolRx, Inc., a private biotechnology company, has agreed to license its immune tolerance therapy for type 1 diabetes (T1D) to Pfizer with...

  • JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

    December 22, 2018

    JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its...

  • Immunology of Diabetes Society Congress Brings World-Renowned Minds to London, England

    October 24, 2018

    Every 18 months, researchers from around the world gather for the Immunology of Diabetes Society (IDS) Congress, which is taking place this...

  • Can a T1D Scientist Learn from a Cancer Researcher? You Bet

    July 20, 2018

    The type 1 diabetes (T1D) research community has continued to reflect on the overlapping biology of cancer immunity and other autoimmune disorders....

  • What is Autoimmunity?

    March 12, 2018

    Fast facts about autoimmune diseases like type 1 diabetes (T1D) Research funded by JDRF in the 1970s and 1980s led to the...

  • T1D Research Highlights of 2017

    January 16, 2018

    JDRF is improving life with type 1 diabetes—and creating a future without it At JDRF, our ultimate goal is finding a cure...

  • One Drug’s To-Do List Could Grow

    July 16, 2015

    An osteoporosis medication could help restore insulin production in people with type 1 diabetes Type 1 diabetes (T1D) is caused by an...

  • Investigating the Role of Regulatory T Cells in T1D

    March 2, 2015

    A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants...

  • Investigating the Role of Regulatory T Cells in T1D

    March 2, 2015

    A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants...

  • Re-educating the Immune System in T1D

    February 2, 2015

    JDRF partner Selecta developed a novel technology for creating a T1D vaccine to potentially halt the disease process It has been more...